These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 6199215

  • 1. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Shimizu Y, Takai Y, Wakamiya N, Ueda S, Kato S, Hamaoka T.
    Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
    [Abstract] [Full Text] [Related]

  • 2. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T.
    J Immunol; 1986 Apr 01; 136(7):2715-9. PubMed ID: 3005417
    [Abstract] [Full Text] [Related]

  • 3. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y, Kosugi A, Yoshioka T, Tomita S, Fujiwara H, Hamaoka T.
    J Immunol; 1985 Jan 01; 134(1):108-13. PubMed ID: 3155458
    [Abstract] [Full Text] [Related]

  • 4. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.
    Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T.
    Eur J Immunol; 1984 Sep 01; 14(9):839-43. PubMed ID: 6236991
    [Abstract] [Full Text] [Related]

  • 5. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H, Moriyama Y, Suda T, Tsuchida T, Shearer GM, Hamaoka T.
    J Immunol; 1984 Mar 01; 132(3):1571-7. PubMed ID: 6198397
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T, Fujiwara H, Mizushima Y, Shearer GM, Hamaoka T.
    J Natl Cancer Inst; 1986 Dec 01; 77(6):1267-72. PubMed ID: 2948049
    [Abstract] [Full Text] [Related]

  • 7. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y, Fujiwara H, Takai Y, Shearer GM, Hamaoka T.
    J Natl Cancer Inst; 1985 Jun 01; 74(6):1269-73. PubMed ID: 3158772
    [Abstract] [Full Text] [Related]

  • 8. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
    Kosugi A, Takai Y, Ogata M, Fujiwara H, Hamaoka T.
    J Leukoc Biol; 1985 May 01; 37(5):629-39. PubMed ID: 3156939
    [Abstract] [Full Text] [Related]

  • 9. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS, Rouse BT.
    J Immunol; 1983 Jul 01; 131(1):479-84. PubMed ID: 6223080
    [Abstract] [Full Text] [Related]

  • 10. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H, Levy RB, Shearer GM.
    J Immunol; 1981 Sep 01; 127(3):940-5. PubMed ID: 6167635
    [Abstract] [Full Text] [Related]

  • 11. Helper cell analysis in cytotoxic T lymphocyte responses. I. Activation of specific and cross-reactive helper effects in two hapten-modified self responses.
    Levy RB, Fujiwara H, Shearer GM.
    Eur J Immunol; 1980 Dec 01; 10(12):904-7. PubMed ID: 6162647
    [Abstract] [Full Text] [Related]

  • 12. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD, Butler LD.
    J Immunol; 1983 Jul 01; 131(1):77-85. PubMed ID: 6190929
    [Abstract] [Full Text] [Related]

  • 13. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H, Aoki H, Yoshioka T, Tomita S, Ikegami R, Hamaoka T.
    J Immunol; 1984 Jul 01; 133(1):509-14. PubMed ID: 6233375
    [Abstract] [Full Text] [Related]

  • 14. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD, Butler LD, Cleveland RP, Moorhead JW, Claman HN, Chiller JC.
    Cell Immunol; 1983 Dec 01; 82(2):378-93. PubMed ID: 6197193
    [Abstract] [Full Text] [Related]

  • 15. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y, Mizuochi T, Fujiwara H, Hamaoka T.
    J Immunol; 1984 Jan 01; 132(1):57-62. PubMed ID: 6197460
    [Abstract] [Full Text] [Related]

  • 16. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M, Shimizu J, Tsuchida T, Takai Y, Fujiwara H, Hamaoka T.
    J Immunol; 1986 Feb 15; 136(4):1178-85. PubMed ID: 2935573
    [Abstract] [Full Text] [Related]

  • 17. Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.
    Fujiwara H, Shearer GM.
    Eur J Immunol; 1981 Sep 15; 11(9):700-4. PubMed ID: 6975212
    [Abstract] [Full Text] [Related]

  • 18. H2Kk can influence whether cytotoxic T lymphocytes recognize trinitrophenyl in association with H2Dk unique or H-2Kk and H-2Dk shared self determinants.
    Fujiwara H, Tsuchida T, Levy RB, Shearer GM.
    J Immunol; 1982 Sep 15; 129(3):1189-93. PubMed ID: 6179996
    [Abstract] [Full Text] [Related]

  • 19. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
    Shimizu Y, Hasumi K, Masubuchi K, Okudaira Y.
    Eur J Immunol; 1988 Nov 15; 18(11):1773-8. PubMed ID: 2974424
    [Abstract] [Full Text] [Related]

  • 20. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A, Kruisbeek AM, Andrysiak PM.
    J Immunol; 1984 May 15; 132(5):2199-209. PubMed ID: 6201534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.